| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.13 | 0.04 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.05 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.05 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.05 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.05 |